Holen Sie sich die Stockscreener-App
92.86
1.86%
-1.89
Schlusskurs vom Vortag:
$94.75
Offen:
$94.7
24-Stunden-Volumen:
1.70M
Relative Volume:
0.88
Marktkapitalisierung:
$18.40B
Einnahmen:
$7.83B
Nettoeinkommen (Verlust:
$825.20M
KGV:
22.61
EPS:
4.1067
Netto-Cashflow:
$1.05B
1W Leistung:
+3.41%
1M Leistung:
-1.37%
6M Leistung:
+0.45%
1J Leistung:
-9.84%
1-Tages-Spanne:
$91.91
$95.25
1-Wochen-Bereich:
$89.50
$95.31
52-Wochen-Spanne:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.86 | 18.78B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Hochstufung | Roth Capital | Neutral → Buy |
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet inks a partnership with PatientIQ - MassDevice
Sivik Global Healthcare LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Absher Wealth Management LLC Invests $2.34 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet stock: Is ZBH underperforming the health care sector? - MSN
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform - marketscreener.com
Evercore ISI Group Upgrades Zimmer Biomet Holdings (ZBH) Rating - GuruFocus
Who Owns Zimmer Biomet? Top Shareholders and Recent Insider Trades - TIKR.com
What analysts say about Zimmer Biomet Holdings Inc stockSmall Cap Stock Opportunities & High Profit Trading Plans - earlytimes.in
Pacer Advisors Inc. Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Calamos Advisors LLC Has $4.66 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet lawsuit against Deloitte Consulting continues to move through New York court - The Journal Gazette
Cervical Total Disc Replacement Device Market 2025 Forecast: - openPR.com
Earnings Update: Will Zimmer Biomet Holdings Inc stock outperform value stocksJuly 2025 Momentum & Daily Technical Stock Forecast Reports - moha.gov.vn
Zimmer Biomet Holdings, Inc.: - marketscreener.com
Boston Trust Walden Corp Has $65.02 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Collagen Meniscus Implant Market Forecast: Unveiling - openPR.com
Kempner Capital Management Inc. Sells 27,095 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ex-Dividend Reminder: John Wiley & Sons, Xcel Energy and Zimmer Biomet Holdings - Nasdaq
Zimmer Biomet Holdings, Inc. $ZBH is QSM Asset Management Ltd's Largest Position - MarketBeat
Voya Investment Management LLC Has $5.36 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zacks Research Predicts Weaker Earnings for Zimmer Biomet - MarketBeat
Is Zimmer Biomet Holdings Inc. stock a buy in volatile marketsGlobal Market Influence & Capital Allocation Recommendations - Bollywood Helpline
Zimmer Biomet: Execution Remains The Sticking Point (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
EBITDA per share of Zimmer Biomet Holdings, Inc. – FWB:ZIM - TradingView — Track All Markets
Wedge Capital Management L L P NC Sells 17,263 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Douglas Lane & Associates LLC Purchases 29,011 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Benson Investment Management Company Inc. Acquires New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Have Endured a 36% Loss From Investing in the Stock Five Years Ago - 富途牛牛
Is Zimmer Biomet Holdings Inc. stock overvalued by current metricsQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pickMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo Finance
How Investors Are Reacting To Zimmer Biomet (ZBH) Dividend Move And OneStep Digital Recovery Partnership - simplywall.st
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Will Zimmer Biomet Holdings Inc. stock benefit from sector rotationMarket Growth Report & Consistent Growth Stock Picks - Улправда
Bactiguard Announces Updated Trauma License Agreement with Zimmer Biomet - marketscreener.com
How Zimmer Biomet Holdings Inc. stock reacts to job market data2025 Major Catalysts & Reliable Price Breakout Alerts - DonanımHaber
How Zimmer Biomet Holdings Inc. (ZIM) stock valuation compares with sectorJuly 2025 Update & Expert-Curated Trade Recommendations - DonanımHaber
Bactiguard Updates Licensing Agreement with Zimmer Biomet - marketscreener.com
Bactiguard announces updated trauma license agreement with Zimmer Biomet - marketscreener.com
Will Zimmer Biomet Holdings Inc. stock outperform value stocksPortfolio Performance Report & Weekly Return Optimization Plans - DonanımHaber
What risks investors should watch in Zimmer Biomet Holdings Inc. stock - DonanımHaber
How Zimmer Biomet Holdings Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Consensus Trade Signals - DonanımHaber
What momentum indicators show for Zimmer Biomet Holdings Inc. stockJuly 2025 Closing Moves & Advanced Technical Signal Analysis - DonanımHaber
Why retail investors pile into Zimmer Biomet Holdings Inc. stockJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Fund Flows: Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pick2025 EndofYear Setup & Fast Exit and Entry Trade Guides - Улправда
How Zimmer Biomet Holdings Inc. stock valuations compare to rivalsQuarterly Market Review & Fast Entry High Yield Stock Tips - DonanımHaber
Why Zimmer Biomet Holdings Inc. stock appeals to dividend seekers2025 Risk Factors & Real-Time Volume Surge Alerts - Улправда
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):